Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
BioMarin Pharmaceutical Inc. (BMRN) had Weighted-Average Shares Outstanding (Diluted) of 197.67M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$766.21M |
|
$105.53M |
|
$195.00M |
|
$571.21M |
|
$636.57M |
|
$129.64M |
|
$11.56M |
|
$141.20M |
|
$141.20M |
|
$105.53M |
|
$105.53M |
|
$105.53M |
|
$105.53M |
|
$129.64M |
|
$145.60M |
|
192.50M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
197.67M |
$0.55 |
|
$0.54 |
|
| Balance Sheet Financials | |
$4.61B |
|
$958.07M |
|
$3.99B |
|
$8.59B |
|
$793.15M |
|
$1.43B |
|
$1.59B |
|
$2.38B |
|
$6.21B |
|
$5.81B |
|
$6.21B |
|
193.27M |
|
| Cash Flow Statement Financials | |
$220.65M |
|
$725.53M |
|
$813.17M |
|
$1.31B |
|
$3.07B |
|
$1.76B |
|
$43.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
0.19 |
|
0.23 |
|
74.55% |
|
16.92% |
|
16.92% |
|
-- |
|
18.43% |
|
13.77% |
|
$199.73M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.15 |
|
0.85 |
|
106.18 |
|
1.70% |
|
1.82% |
|
1.23% |
|
1.38% |
|
$32.14 |
|
$1.01 |
|
$1.12 |
|